Lisa M. Rimsza

Hematology

5777 E Mayo Blvd
Phoenix, AZ 85054

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 159 publications

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

Journal: JAMA oncology

Published: February 26, 2026

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

Journal: The American journal of surgical pathology

Published: October 28, 2025

Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup.

Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup.

Journal: Science advances

Published: October 17, 2025

Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup.

Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup.

Journal: Science advances

Published: October 17, 2025

Advancing HIV and Cancer Research: Implementing an AIDS and Cancer Specimen Resource in Latin America.

Advancing HIV and Cancer Research: Implementing an AIDS and Cancer Specimen Resource in Latin America.

Journal: Biopreservation and biobanking

Published: August 08, 2025

Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study.

Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study.

Journal: Leukemia & lymphoma

Published: August 06, 2025

Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma.

Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma.

Journal: Leukemia

Published: July 03, 2025

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Journal: Blood cancer journal

Published: June 13, 2025

Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemoimmunotherapy on the SWOG S0016 trial.

Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemoimmunotherapy on the SWOG S0016 trial.

Journal: Haematologica

Published: April 17, 2025

Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma.

Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma.

Journal: Blood advances

Published: April 14, 2025

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Journal: medRxiv : the preprint server for health sciences

Published: March 31, 2025

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Journal: Blood advances

Published: March 26, 2025

Showing 1-12 of 159

Last Updated: 09/26/2026